|
1
|
Choi SW and Mason JB: Folate and
carcinogenesis: an integrated scheme. J Nutr. 130:129–132.
2000.PubMed/NCBI
|
|
2
|
Duthie SJ: Folic acid deficiency and
cancer: mechanisms of DNA instability. Br Med Bull. 55:578–592.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mason JB and Choi SW: The mechanisms by
which folate depletion enhances colorectal carcinogenesis: a
unified scheme. Nestle Nutr Workshop Ser Clin Perform Programme.
4:87–101. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Whiteside MA, Heimburger DC and Johanning
GL: Micronutrients and cancer therapy. Nutr Rev. 62:142–147. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Peyrin-Biroulet L, Barraud H, Ancel D,
Petit-Laurent F, Bigard MA, Gueant JL and Bronowicki JP: Folate
metabolism and colorectal carcinogenesis. Gastroenterol Clin Biol.
28:582–592. 2004. View Article : Google Scholar
|
|
6
|
Kato I, Dnistrian AM, Schwartz M, et al:
Serum folate, homocysteine and colorectal cancer risk in women: a
nested case-control study. Br J Cancer. 79:1917–1922. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen K, Song L, Jin MJ, Fan CH, Jiang QT
and Yu WP: Association between genetic polymorphisms in folate
metabolic enzyme genes and colorectal cancer: a nested case-control
study. Zhonghua Zhong Liu Za Zhi. 28:429–432. 2006.(In
Chinese).
|
|
8
|
Le Marchand L, Wilkens LR, Kolonel LN and
Henderson BE: The MTHFR C677T polymorphism and colorectal cancer:
the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev.
14:1198–1203. 2005.PubMed/NCBI
|
|
9
|
Kim JK, Kim S, Han JH, et al:
Polymorphisms of 5,10-methylenetetrahydrofolate reductase and risk
of stomach cancer in a Korean population. Anticancer Res.
25:2249–2252. 2005.PubMed/NCBI
|
|
10
|
Zeybek U, Yaylim I, Yilmaz H, et al:
Methylenetetrahydrofolate reductase C677T polymorphism in patients
with gastric and colorectal cancer. Cell Biochem Funct. 25:419–422.
2007. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Vollset SE, Igland J, Jenab M, et al: The
association of gastric cancer risk with plasma folate, cobalamin,
and methylenetetrahydrofolate reductase polymorphisms in the
European Prospective Investigation into Cancer and Nutrition.
Cancer Epidemiol Biomarkers Prev. 16:2416–2424. 2007. View Article : Google Scholar
|
|
12
|
Frosst P, Blom HJ, Milos R, et al: A
candidate genetic risk factor for vascular disease: a common
mutation in methylenetetrahydrofolate reductase. Nat Genet.
10:111–113. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Finkelstein JD: The metabolism of
homocysteine: pathways and regulation. Eur J Pediatr. 157:40–44.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gudnason V, Stansbie D, Scott J, Bowron A,
Nicaud V and Humphries S: C677T (thermolabile alanine/valine)
polymorphism in methylenetetrahydrofolate reductase (MTHFR): its
frequency and impact on plasma homocysteine concentration in
different European populations. Atherosclerosis. 136:347–354. 1998.
View Article : Google Scholar
|
|
15
|
Hultdin J, Van Guelpen B, Bergh A,
Hallmans G and Stattin P: Plasma folate, vitamin B12, and
homocysteine and prostate cancer risk: a prospective study. Int J
Cancer. 113:819–824. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Martínez-Poveda B, Chavarría T,
Sánchez-Jiménez F, Quesada AR and Medina MA: An in vitro evaluation
of the effects of homocysteine thiolactone on key steps of
angiogenesis and tumor invasion. Biochem Biophys Res Commun.
311:649–653. 2003.PubMed/NCBI
|
|
17
|
Chavarría T, Rodríguez-Nieto S,
Sánchez-Jiménez F, Quesada AR and Medina MA: Homocysteine is a
potent inhibitor of human tumor cell gelatinases. Biochem Biophys
Res Commun. 303:572–575. 2003.PubMed/NCBI
|
|
18
|
Schroecksnadel K, Frick B, Fiegl M,
Winkler C, Denz HA and Fuchs D: Hyperhomocysteinaemia and immune
activation in patients with cancer. Clin Chem Lab Med. 45:47–53.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lever M, George PM, Dellow WJ, Scott RS
and Chambers ST: Homocysteine, glycine betaine, and
N,N-dimethylglycine in patients attending a lipid clinic.
Metabolism. 54:1–14. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Morgenstern I, Raijmakers MT, Peters WH,
et al: Homocysteine, cysteine, and glutathione in human colonic
mucosa: elevated levels of homocysteine in patients with
inflammatory bowel disease. Dig Dis Sci. 48:2083–2090. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Poddar R, Sivasubramanian N, DiBello PM,
et al: Homocysteine induces expression and secretion of monocyte
chemoattractant protein-1 and interleukin-8 in human aortic
endothelial cells: implications for vascular disease. Circulation.
103:2717–2723. 2001. View Article : Google Scholar
|
|
22
|
Kim YI, Pogribny IP, Basnakian AG, et al:
Folate deficiency in rats induces DNA strand breaks and
hypomethylation within the p53 tumor suppressor gene. Am J Clin
Nutr. 65:46–52. 1997.PubMed/NCBI
|
|
23
|
Blount BC, Mack MM, Wehr CM, et al: Folate
deficiency causes uracil misincorporation into human DNA and
chromosome breakage: implications for cancer and neuronal damage.
Proc Natl Acad Sci USA. 94:3290–3295. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Adams M, Smith PD, Martin D, Thompson JR,
Lodwick D and Samani NJ: Genetic analysis of thermolabile
methylenetetrahydrofolate reductase as a risk factor for myocardial
infarction. QJM. 89:437–444. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zuntar I, Topić E, Vukosavić D, et al:
Croatian population data for the C677T polymorphism in
methylenetetrahydrofolate reductase: frequencies in healthy and
atherosclerotic study groups. Clin Chim Acta. 335:95–100. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Motulsky AG: Nutritional ecogenetics:
homocysteine-related arteriosclerotic vascular disease, neural tube
defects, and folic acid. Am J Hum Genet. 58:17–20. 1996.PubMed/NCBI
|
|
27
|
Zhang L, Miyaki K, Araki J, Nakayama T and
Muramatsu M: The relation between nicotinamide N-methyltransferase
gene polymorphism and plasma homocysteine concentration in healthy
Japanese men. Thromb Res. 121:55–58. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Goracy I, Cyrylowski L, Kaczmarczyk M, et
al: C677T polymorphism of the methylenetetrahydrofolate reductase
gene and the risk of ischemic stroke in Polish subjects. J Appl
Genet. 50:63–67. 2009. View Article : Google Scholar : PubMed/NCBI
|
